Wellington Management Group
CADX

Wellington Management Group’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Wellington Management Group’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,152,679
Closed -$46.6M – 2324
2013
Q4 		$46.6M Sell
5,152,679
-815,467
-14% -$5.89M 0.01% 764
2013
Q3 		$37.7M Sell
5,968,146
-366,775
-6% -$2.33M 0.01% 797
2013
Q2 		$43.2M Buy
+6,334,921
New +$44.1M 0.01% 737

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group's CADX Position: Q1 2014 in Review

Wellington Management Group sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 5,152,679 shares — an estimated $46.6M sold.

Wellington Management Group first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $46.6M in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Wellington Management Group reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Wellington Management Group sold 5,152,679 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $46.6M.
  • Wellington Management Group first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Wellington Management Group's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $46.6M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Wellington Management Group's 13F filing for Q1 2014, filed 15 May 2014.